1. Home
  2. NNNN vs UTF Comparison

NNNN vs UTF Comparison

Compare NNNN & UTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NNNN
  • UTF
  • Stock Information
  • Founded
  • NNNN 2021
  • UTF 2004
  • Country
  • NNNN Germany
  • UTF United States
  • Employees
  • NNNN N/A
  • UTF N/A
  • Industry
  • NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • UTF Finance Companies
  • Sector
  • NNNN Health Care
  • UTF Finance
  • Exchange
  • NNNN Nasdaq
  • UTF Nasdaq
  • Market Cap
  • NNNN 2.2B
  • UTF 2.4B
  • IPO Year
  • NNNN 2025
  • UTF N/A
  • Fundamental
  • Price
  • NNNN $23.92
  • UTF $23.98
  • Analyst Decision
  • NNNN
  • UTF
  • Analyst Count
  • NNNN 0
  • UTF 0
  • Target Price
  • NNNN N/A
  • UTF N/A
  • AVG Volume (30 Days)
  • NNNN 76.5K
  • UTF 171.7K
  • Earning Date
  • NNNN 11-07-2025
  • UTF 01-01-0001
  • Dividend Yield
  • NNNN N/A
  • UTF 7.19%
  • EPS Growth
  • NNNN N/A
  • UTF N/A
  • EPS
  • NNNN 0.06
  • UTF 2.84
  • Revenue
  • NNNN $8,185,146.00
  • UTF $138,636,669.00
  • Revenue This Year
  • NNNN N/A
  • UTF N/A
  • Revenue Next Year
  • NNNN N/A
  • UTF N/A
  • P/E Ratio
  • NNNN $442.46
  • UTF $9.16
  • Revenue Growth
  • NNNN 21.95
  • UTF 19.80
  • 52 Week Low
  • NNNN $5.18
  • UTF $22.05
  • 52 Week High
  • NNNN $55.65
  • UTF $26.53
  • Technical
  • Relative Strength Index (RSI)
  • NNNN 35.64
  • UTF 39.66
  • Support Level
  • NNNN $26.05
  • UTF $23.89
  • Resistance Level
  • NNNN $30.65
  • UTF $24.19
  • Average True Range (ATR)
  • NNNN 2.72
  • UTF 0.25
  • MACD
  • NNNN -0.11
  • UTF 0.06
  • Stochastic Oscillator
  • NNNN 19.80
  • UTF 19.10

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

About UTF Cohen & Steers Infrastructure Fund Inc

Cohen & Steers Infrastructure Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is total return with an emphasis on income. It invests majority of its managed assets in securities issued by infrastructure companies, which consists of utilities, pipelines, toll roads, airports, railroads, ports, telecommunications companies, and other infrastructure companies, under normal market conditions.

Share on Social Networks: